MetaADEDB 2.0 @ LMMD
Penicillin G
(IYNDLOXRXUOGIU-LQDWTQKMSA-M)
Structure
SMILES
O=C(Cc1ccccc1)N[C@@H]1C(=O)N2[C@@H]1SC([C@@H]2C(=O)[O-])(C)C.[K+]
Molecular Formula:
C16H17KN2O4S
Molecular Weight:
372.480
Log P:
-0.1451
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
114.84
CAS Number(s):
113-98-4
Synonym(s)
1.
Penicillin G
2.
Benzylpenicillin
3.
Benpen
4.
Benzylpenicillin Potassium
5.
Coliriocilina
6.
Crystapen
7.
Or-pen
8.
Parcillin
9.
Pekamin
10.
Pengesod
11.
Penibiot
12.
Penicilina G Llorente
13.
Penicillin G Jenapharm
14.
Penicillin G Potassium
15.
Penicillin G Sodium
16.
Penicillin Grünenthal
17.
Penilevel
18.
Peniroger
19.
Pfizerpen
20.
Sodiopen
21.
Sodipen
22.
Sodium Benzylpenicillin
23.
Sodium Penicillin
24.
Unicilina
25.
Ursopen
26.
Van-Pen-G
External Link(s)
MeSHD010400
PubChem Compound23664709
102090456
ChEBI7963
CHEMBLCHEMBL1223
KEGGdr:D01053
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1No adverse eventFAERS: 66US FAERS
2UrticariaFAERS: 47
Canada Vigilance: 2
Canada Vigilance
US FAERS
3HypersensitivityFAERS: 23US FAERS
4SwellingFAERS: 19US FAERS
5PruritusFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
6NauseaFAERS: 7US FAERS
7VomitingFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
8ErythemaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Injection site painFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
10Burning sensationFAERS: 3US FAERS
11Infusion site irritationFAERS: 3US FAERS
12AgranulocytosisFAERS: 2US FAERS
13AlopeciaFAERS: 2US FAERS
14Cardiac ArrestFAERS: 2US FAERS
15DysgeusiaFAERS: 2US FAERS
16PanniculitisFAERS: 2US FAERS
17Toxicity to various agentsFAERS: 2US FAERS
18Anaphylactic shockFAERS: 1US FAERS
19Blood glucose increasedFAERS: 1US FAERS
20Cerebrovascular accidentFAERS: 1US FAERS
21CyanosisFAERS: 1US FAERS
22Diabetes MellitusFAERS: 1US FAERS
23DiscomfortFAERS: 1US FAERS
24DizzinessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Drug dose omissionFAERS: 1US FAERS
26Drug exposure during pregnancyFAERS: 1US FAERS
27DysuriaFAERS: 1US FAERS
28Feeling abnormalFAERS: 1US FAERS
29FormicationFAERS: 1US FAERS
30HeadacheFAERS: 1US FAERS
31Infusion Site ExtravasationFAERS: 1US FAERS
32Infusion site painFAERS: 1US FAERS
33Injection site indentationFAERS: 1US FAERS
34Injection site irritationFAERS: 1US FAERS
35MalaiseFAERS: 1US FAERS
36MonoplegiaFAERS: 1US FAERS
37MyopericarditisFAERS: 1US FAERS
38NervousnessFAERS: 1US FAERS
39PainFAERS: 1US FAERS
40PalpitationsFAERS: 1US FAERS
41Peripheral swellingFAERS: 1US FAERS
42Rash erythematousFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
43Seizure like phenomenaFAERS: 1US FAERS
44Stevens-Johnson SyndromeFAERS: 1US FAERS
45SyncopeFAERS: 1US FAERS
46Toxic Epidermal NecrolysisFAERS: 1US FAERS
47Ventricular FibrillationFAERS: 1US FAERS
48Visual ImpairmentFAERS: 1US FAERS
49Anaphylactoid ReactionCanada Vigilance: 1Canada Vigilance
50DermatitisCanada Vigilance: 1Canada Vigilance
51LymphadenopathyCanada Vigilance: 1Canada Vigilance
52PallorCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.